机器人经裂孔食管切除术淋巴结检出数是否达标:基于AJCC与NCCN标准的评估
≥15枚组淋巴血管侵犯比例更高(32.1% vs 9.0%,p=0.012),围术期并发症与死亡率两组相似;中位随访47.8个月,DFS与OS差异无统计学意义(p=0.430与p=0.555),但≥15枚组3年DFS与OS数值上更高。
要点
- 机器人经裂孔食管切除术中检出≥15枚淋巴结与更好的病理分期质量相关,且不增加围术期并发症与死亡。
- ≥15枚组淋巴血管侵犯比例显著更高(32.1% vs 9.0%,p=0.012),淋巴结阳性率有升高趋势(50.0% vs 30.4%,p=0.079)。
- 两组DFS与OS差异未达统计学意义,但≥15枚组3年DFS(65% vs 49%)与OS(75% vs 56%)数值更高。
核心结论
- 机器人经裂孔食管切除术中检出≥15枚淋巴结与改善的病理特征评估相关,且不增加围术期并发症。
- 尽管生存差异未达统计学意义,更高淋巴结检出数显示出持续改善结局的趋势,支持其作为机器人食管切除术的质量指标。
研究设计与样本
- 单中心前瞻性维护队列的回顾性分析,纳入2012至2024年因食管胃结合部腺癌行机器人经裂孔食管切除术的患者。
- 比较临床病理变量、围术期结局、无病生存(DFS)与总生存(OS),生存分析采用Kaplan-Meier法。
主要发现
- 两组基线特征可比。
- ≥15枚组淋巴血管侵犯比例更高(32.1% vs 9.0%,p=0.012),淋巴结阳性率有升高趋势(50.0% vs 30.4%,p=0.079)。
- 围术期结局包括并发症与死亡率两组相似。
- 中位随访47.8个月,<15枚组中位DFS为33.6个月,≥15枚组为97.9个月(p=0.430);中位OS分别为未达到与97.9个月(p=0.555)。
- 3年DFS(65% vs 49%)与OS(75% vs 56%)在≥15枚组数值上更高。
关键数值与推荐
- 当前指南推荐食管癌分期评估至少检出15枚淋巴结,依据AJCC与NCCN标准。
- 本研究以淋巴结检出数<15枚与≥15枚作为分组阈值。
临床怎么用
- 在机器人经裂孔食管切除术中应努力达到至少15枚淋巴结检出,以提升病理分期质量,且不增加围术期风险。
- 淋巴结检出数可作为机器人食管切除术的质量评价指标之一。
局限性
- 生存差异未达统计学意义,可能受样本量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adequate lymph node (LN) retrieval is a key determinant of staging quality in esophageal cancer, with current guidelines recommending evaluation of at least 15 nodes. However, the relevance of this threshold in robotic transhiatal esophagectomy (THE) remains unclear. METHODS: We performed a retrospective analysis of a prospectively maintained single-center cohort of patients undergoing robotic THE for esophagogastric junction adenocarcinoma (2012-2024). Patients were stratified by LN yield (< 15 vs ≥ 15) according to AJCC and NCCN. Clinicopathologic variables, perioperative outcomes, disease-free survival (DFS), and overall survival (OS) were compared. Survival was assessed using Kaplan-Meier analysis. RESULTS: Eighty-four patients were included, with 56 (66.7%) in the < 15 LN group and 28 (33.3%) in the ≥ 15 LN group. Baseline characteristics were comparable. Higher LN yield was associated with increased lymphovascular invasion (32.1% vs 9.0%, p = 0.012) and a trend toward higher nodal positivity (50.0% vs 30.4%, p = 0.079). Perioperative outcomes, including complications and mortality, were similar between groups. Median follow-up was 47.8 months. Median DFS was 33.6 months in the < 15 LN group and 97.9 months in the ≥ 15 LN group (p = 0.430), while median OS was not reached and 97.9 months, respectively (p = 0.555). At 3 years, DFS (65% vs 49%) and OS (75% vs 56%) were numerically higher in the ≥ 15 LN group. CONCLUSIONS: Retrieval of ≥ 15 lymph nodes during robotic THE is associated with improved pathologic characterization without increasing perioperative morbidity. Although survival differences were not statistically significant, higher LN yield demonstrated a consistent trend toward improved outcomes, supporting its role as a quality metric in robotic esophagectomy.
引用
- Vanterpool G, Mascherini J, Sucandy I, et al. Is robotic surgery meeting nodal benchmarks? AJCC and NCCN-based evaluation of lymph node yield and survival in robotic transhiatal esophagectomy. Surg Endosc. 2026. PMID: 42791411. doi:10.1007/s00464-026-13317-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。